TET2 and hematologic disorder: Enzymes of the TET family and especially TET2 and TET3 regulate enhancer activity and DNA methylation dynamics during B cell development [154,155], while TET2 mutations or defects are frequent in hematological malignancies such as diffuse large B cell lymphoma [156,157].